{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:20:39Z","timestamp":1793892039760,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amepre.2021.05.044","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:29:02Z","timestamp":1634689742000},"page":"S118-S129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"S1","title":["Syringe Services Programs\u2019 Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them"],"prefix":"10.1016","volume":"61","author":[{"given":"Dita","family":"Broz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5055-9708","authenticated-orcid":false,"given":"Neal","family":"Carnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-8937","authenticated-orcid":false,"given":"Johanna","family":"Chapin-Bardales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-1153","authenticated-orcid":false,"given":"Senad","family":"Handanagic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Paul","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice K.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0001","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/S2352-3018(20)30082-5","article-title":"HIV outbreaks among people who inject drugs in Europe, North America, and Israel","volume":"7","author":"Des Jarlais","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.amepre.2021.05.044_bib0002","series-title":"2020 global AIDS update Seizing the moment\u2014tackling entrenched inequalities to end epidemics","year":"2020"},{"key":"10.1016\/j.amepre.2021.05.044_bib0003","volume":"31","year":"2020"},{"key":"10.1016\/j.amepre.2021.05.044_bib0004","unstructured":"Centers for Disease Control and Prevention. HIV\/AIDS surveillance report, 1994;6(no. 2). Atlanta, GA: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-1994-vol-6-2.pdf. Accessed December 28, 2020."},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/QAD.0000000000001039","article-title":"HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks","volume":"30","author":"Des Jarlais","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.amepre.2021.05.044_bib0006","unstructured":"HIV and people who inject drugs. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/hiv\/group\/hiv-idu.html. Accessed December 8, 2010."},{"issue":"suppl 5","key":"10.1016\/j.amepre.2021.05.044_bib0007","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","article-title":"Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United States, 2016-2019: perspectives on recent experience and lessons learned","volume":"222","author":"Lyss","year":"2020","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.amepre.2021.05.044_bib0008","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0009","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1465-3362.2011.00291.x","article-title":"The prescription drug epidemic in the United States: a perfect storm","volume":"30","author":"Maxwell","year":"2011","journal-title":"Drug Alcohol Rev"},{"issue":"26","key":"10.1016\/j.amepre.2021.05.044_bib0010","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50\u201351","key":"10.1016\/j.amepre.2021.05.044_bib0011","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2013United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2021.05.044_bib0012","series-title":"Drug overdose deaths in the United States, 1999\u20132018","author":"Hedegaard","year":"2020"},{"issue":"suppl 5","key":"10.1016\/j.amepre.2021.05.044_bib0013","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/infdis\/jiaa432","article-title":"Infectious diseases and injection drug use: public health burden and response","volume":"222","author":"Levitt","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2021.05.044_bib0014","unstructured":"People coinfected with HIV and viral hepatitis. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/hepatitis\/populations\/hiv.htm#ref11. Updated September 21, 2020. Accessed December 28, 2020."},{"key":"10.1016\/j.amepre.2021.05.044_bib0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ebiom.2018.10.007","article-title":"A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015","volume":"37","author":"Ramachandran","year":"2018","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0017","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/cid\/ciz321","article-title":"Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study","volume":"70","author":"Goedel","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.amepre.2021.05.044_bib0018","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/S2352-3018(18)30176-0","article-title":"Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study","volume":"5","author":"Gonsalves","year":"2018","journal-title":"Lancet HIV"},{"issue":"6-7","key":"10.1016\/j.amepre.2021.05.044_bib0019","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/10826080600669579","article-title":"Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence","volume":"41","author":"Wodak","year":"2006","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"36","key":"10.1016\/j.amepre.2021.05.044_bib0021","first-page":"10038","article-title":"Determination that a demonstration needle exchange program would be effective in reducing drug abuse and the risk of acquired immune deficiency syndrome infection among intravenous drug users","volume":"76","year":"2011","journal-title":"Fed Regist"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0022","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10461-015-1143-6","article-title":"Impact evaluation of a policy intervention for HIV prevention in Washington, DC","volume":"20","author":"Ruiz","year":"2016","journal-title":"AIDS Behav"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0023","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/QAI.0000000000002176","article-title":"Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia","volume":"82","author":"Ruiz","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0024","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"Macarthur","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2021.05.044_bib0026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2019.04.025","article-title":"Syringe disposal among people who inject drugs before and after the implementation of a syringe services program","volume":"202","author":"Levine","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0027","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","article-title":"Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors","volume":"19","author":"Hagan","year":"2000","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2005.11.015","article-title":"Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial","volume":"83","author":"Strathdee","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.amepre.2021.05.044_bib0029","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s10461-019-02467-y","article-title":"Implementing an updated \u201cBreak the Cycle\u201d intervention to reduce initiating persons into injecting drug use in an Eastern European and a U.S. \u201copioid epidemic\u201d setting","volume":"23","author":"Des Jarlais","year":"2019","journal-title":"AIDS Behav"},{"issue":"12","key":"10.1016\/j.amepre.2021.05.044_bib0030","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2105\/AJPH.90.12.1933","article-title":"Trends in crime and the introduction of a needle exchange program","volume":"90","author":"Marx","year":"2000","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0031","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00042560-200111010-00014","article-title":"Needle exchange programs and experience of violence in an inner city neighborhood","volume":"28","author":"Galea","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00126334-200306010-00014","article-title":"Needle exchange and injection drug use frequency: a randomized clinical trial","volume":"33","author":"Fisher","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2021.05.044_bib0033","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.drugpo.2007.11.011","article-title":"Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the U.S. in which heroin is the dominant injected drug","volume":"19","author":"Tempalski","year":"2008","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0034","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/cid\/cix333","article-title":"Geographic disparities in access to syringe services programs among young persons with hepatitis C virus infection in the United States","volume":"65","author":"Canary","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2021.05.044_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugpo.2019.04.006","article-title":"Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S","volume":"70","author":"Jones","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"11","key":"10.1016\/j.amepre.2021.05.044_bib0036","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2105\/AJPH.2019.305268","article-title":"Paraphernalia laws, criminalizing possession and distribution of items used to consume illicit drugs, and injection-related harm","volume":"109","author":"Davis","year":"2019","journal-title":"Am J Public Health"},{"issue":"9","key":"10.1016\/j.amepre.2021.05.044_bib0037","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1007\/s10461-020-02886-2","article-title":"The impact of COVID-19 on syringe services programs in the United States","volume":"24","author":"Glick","year":"2020","journal-title":"AIDS Behav"},{"issue":"7","key":"10.1016\/j.amepre.2021.05.044_bib0038","doi-asserted-by":"crossref","first-page":"e25583","DOI":"10.1002\/jia2.25583","article-title":"Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks","volume":"23","author":"Vasylyeva","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.amepre.2021.05.044_bib0039","unstructured":"Ending the HIV epidemic in the U.S. (EHE). Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/endhiv\/index.html. Accessed January 21, 2021."},{"key":"10.1016\/j.amepre.2021.05.044_bib0040","series-title":"Evidence for action technical papers: effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users","year":"2004"},{"key":"10.1016\/j.amepre.2021.05.044_bib0041","series-title":"Policy brief: provision of sterile injecting equipment to reduce HIV transmission","year":"2004"},{"key":"10.1016\/j.amepre.2021.05.044_bib0042","unstructured":"A Dave Purchase initiative. North American Syringe Exchange Network. https:\/\/nasen.org\/. Accessed December 28, 2020."},{"key":"10.1016\/j.amepre.2021.05.044_bib0043","series-title":"Syringe services programs (SSPs): developing, implementing and monitoring programs","year":"2016"},{"issue":"9737","key":"10.1016\/j.amepre.2021.05.044_bib0044","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.amepre.2021.05.044_bib0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas - United States, 2013","volume":"64","author":"Des Jarlais","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0046","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12954-018-0212-3","article-title":"Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact","volume":"15","author":"Strike","year":"2018","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0047","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.drugpo.2010.02.001","article-title":"Optimal provision of needle and syringe programmes for injecting drug users: a systematic review","volume":"21","author":"Jones","year":"2010","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0048","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0033354920941184","article-title":"Roles for pharmacists in the \u201cEnding the HIV Epidemic: A Plan for America\u201d initiative","volume":"135","author":"McCree","year":"2020","journal-title":"Public Health Rep"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0049","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/add.13593","article-title":"Effectiveness of pharmacy-based needle\/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis","volume":"112","author":"Sawangjit","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.amepre.2021.05.044_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2018.02.024","article-title":"Predicting pharmacy syringe sales to people who inject drugs: policy, practice and perceptions","volume":"56","author":"Meyerson","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0051","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1521\/aeap.2007.19.2.97","article-title":"Hospital- versus community-based syringe exchange: a randomized controlled trial","volume":"19","author":"Masson","year":"2007","journal-title":"AIDS Educ Prev"},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0052","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/10826080903080631","article-title":"Organizational issues in the implementation of a hospital-based syringe exchange program","volume":"45","author":"Masson","year":"2010","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0053","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12954-020-00403-1","article-title":"HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service","volume":"17","author":"Torres-Leguizamon","year":"2020","journal-title":"Harm Reduct J"},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0054","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.drugpo.2007.07.006","article-title":"The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings","volume":"19","author":"Islam","year":"2008","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugpo.2008.09.002","article-title":"Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico","volume":"20","author":"Philbin","year":"2009","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0056","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12954-019-0292-8","article-title":"Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia","volume":"16","author":"Otiashvili","year":"2019","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0057","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/S2352-3018(18)30292-3","article-title":"Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs","volume":"6","author":"Reddon","year":"2019","journal-title":"Lancet HIV"},{"issue":"15","key":"10.1016\/j.amepre.2021.05.044_bib0058","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jama.1995.03530150050033","article-title":"Maintaining low HIV seroprevalence in populations of injecting drug users","volume":"274","author":"Des Jarlais","year":"1995","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.amepre.2021.05.044_bib0059","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2105\/AJPH.2003.036517","article-title":"HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services","volume":"95","author":"Des Jarlais","year":"2005","journal-title":"Am J Public Health"},{"issue":"9","key":"10.1016\/j.amepre.2021.05.044_bib0060","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s10461-017-1762-1","article-title":"Syringe sharing among a prospective cohort of street-involved youth: implications for needle distribution programs","volume":"21","author":"Bozinoff","year":"2017","journal-title":"AIDS Behav"},{"key":"10.1016\/j.amepre.2021.05.044_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102716","article-title":"Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: a latent class analysis","volume":"78","author":"Bartholomew","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"8","key":"10.1016\/j.amepre.2021.05.044_bib0062","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2105\/AJPH.2009.178467","article-title":"Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes","volume":"100","author":"Kerr","year":"2010","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0063","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/QAI.0000000000001615","article-title":"Reduction of injection-related risk behaviors after emergency implementation of a syringe services program during an HIV outbreak","volume":"77","author":"Patel","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0064","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1360-0443.2006.01741.x","article-title":"Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users","volume":"102","author":"Bluthenthal","year":"2007","journal-title":"Addiction"},{"issue":"2\u20133","key":"10.1016\/j.amepre.2021.05.044_bib0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","article-title":"Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients","volume":"89","author":"Bluthenthal","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.amepre.2021.05.044_bib0066","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/pch\/pxy129","article-title":"Needle stick injuries in the community","volume":"23","author":"Moore","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.amepre.2021.05.044_bib0067","series-title":"Needs-based distribution at syringe services programs","year":"2020"},{"key":"10.1016\/j.amepre.2021.05.044_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.03.002","article-title":"Peering into the literature: a systematic review of the roles of people who inject drugs in harm reduction initiatives","volume":"151","author":"Marshall","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0069","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/jurban\/jtg035","article-title":"Secondary syringe exchange among injection drug users","volume":"80","author":"Snead","year":"2003","journal-title":"J Urban Health"},{"key":"10.1016\/j.amepre.2021.05.044_bib0070","unstructured":"New York City Department of Health and Mental Hygiene. Recommended best practices for effective syringe exchange programs in the United States: results of a consensus meeting. New York, NY: New York City Department of Health and Mental Hygiene. http:\/\/www.santacruzhealth.com\/Portals\/7\/Pdfs\/SEP%20Recs%20-%20Consensus%20Meeting.pdf. Published 2009. Accessed December 28, 2020."},{"key":"10.1016\/j.amepre.2021.05.044_bib0071","series-title":"Syringe services programs: a technical package of effective strategies and approaches for planning, design, and implementation","author":"Javed","year":"2020"},{"issue":"9033","key":"10.1016\/j.amepre.2021.05.044_bib0072","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(96)02536-6","article-title":"HIV incidence among injecting drug users in New York City syringe-exchange programmes","volume":"348","author":"Des Jarlais","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0073","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9343(93)90263-O","article-title":"Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut","volume":"95","author":"Heimer","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.amepre.2021.05.044_bib0074","series-title":"HIV infection risk, prevention, and testing behaviors among persons who inject drugs\u2014national HIV Behavioral Surveillance: injection Drug Use, 23 U.S. cities, 2018. HIV Surveillance Special Report 24","year":"2020"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2005.06.008","article-title":"Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement","volume":"81","author":"Heinzerling","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0076","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/QAI.0000000000001792","article-title":"Availability of HIV and HCV on-site testing and treatment at syringe service programs in the United States","volume":"79","author":"Behrends","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amepre.2021.05.044_bib0077","series-title":"Data on substance abuse treatment facilities","year":"2019"},{"issue":"25","key":"10.1016\/j.amepre.2021.05.044_bib0078","doi-asserted-by":"crossref","first-page":"776","DOI":"10.15585\/mmwr.mm6925a2","article-title":"HIV testing trends at visits to physician offices, community health centers, and emergency departments - United States, 2009\u20132017","volume":"69","author":"Hoover","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2021.05.044_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102875","article-title":"Impact of routine opt-out HIV\/HCV screening on testing uptake at a syringe services program: an interrupted time series analysis","volume":"84","author":"Bartholomew","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/10550887.2020.1771235","article-title":"Factors associated with HIV testing among people who inject drugs: a meta-analysis","volume":"38","author":"Bayani","year":"2020","journal-title":"J Addict Dis"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0081","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","article-title":"Barriers to accessing generic health and social care services: a qualitative study of injecting drug users","volume":"16","author":"Neale","year":"2008","journal-title":"Health Soc Care Community"},{"issue":"8","key":"10.1016\/j.amepre.2021.05.044_bib0082","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/0002764298041008007","article-title":"A comparison of the need for health care and use of health care by injection-drug users, other chronic drug users, and nondrug users","volume":"41","author":"Chitwood","year":"1998","journal-title":"Am Behav Sci"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0083","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","article-title":"Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs","volume":"15","author":"Biello","year":"2018","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0084","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1521\/aeap.2018.30.5.369","article-title":"I don't need PrEP right now\u201d: a qualitative exploration of the barriers to PrEP care engagement through the application of the health belief model","volume":"30","author":"Felsher","year":"2018","journal-title":"AIDS Educ Prev"},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0085","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","article-title":"Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study","volume":"24","author":"Allen","year":"2020","journal-title":"AIDS Behav"},{"issue":"9","key":"10.1016\/j.amepre.2021.05.044_bib0086","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/09540121.2016.1153595","article-title":"HIV providers\u2019 likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report","volume":"28","author":"Adams","year":"2016","journal-title":"AIDS Care"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0087","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10461-019-02680-9","article-title":"Rapid identification and investigation of an HIV risk network among people who inject drugs \u2013Miami, FL, 2018","volume":"24","author":"Tookes","year":"2020","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0088","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12889-018-6314-8","article-title":"Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions","volume":"19","author":"Bazzi","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0089","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10461-016-1612-6","article-title":"Primary care physicians\u2019 willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs","volume":"21","author":"Edelman","year":"2017","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12954-017-0178-6","article-title":"Harm reduction in the USA: the research perspective and an archive to David Purchase","volume":"14","author":"Des Jarlais","year":"2017","journal-title":"Harm Reduct J"},{"issue":"9883","key":"10.1016\/j.amepre.2021.05.044_bib0091","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0092","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/09540121.2020.1822506","article-title":"Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia","volume":"33","author":"Schneider","year":"2021","journal-title":"AIDS Care"},{"issue":"14","key":"10.1016\/j.amepre.2021.05.044_bib0093","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10826084.2020.1823419","article-title":"HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016-2018","volume":"55","author":"Walters","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.amepre.2021.05.044_bib0094","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2018.08.014","article-title":"PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland","volume":"195","author":"Sherman","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2021.05.044_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","article-title":"Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC","volume":"164","author":"Kuo","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0096","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231424","article-title":"Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida","volume":"15","author":"Jo","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0097","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","article-title":"The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review","volume":"25","author":"Mistler","year":"2021","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0098","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/OLQ.0000000000000728","article-title":"An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users","volume":"45","author":"Roth","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.amepre.2021.05.044_bib0099","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1521\/aeap.2019.31.4.363","article-title":"Medical providers and harm reduction views on pre-exposure prophylaxis for HIV prevention among people who inject drugs","volume":"31","author":"Hershow","year":"2019","journal-title":"AIDS Educ Prev"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s10461-020-02979-y","article-title":"A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection","volume":"25","author":"Blackstock","year":"2021","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0101","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","article-title":"Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE Demonstration Study","volume":"86","author":"Roth","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amepre.2021.05.044_bib0102","series-title":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.amepre.2021.05.044_bib0103","series-title":"CDC HIV prevention progress report, 2019","year":"2019"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","article-title":"Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV?","volume":"15","author":"Rich","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"18","key":"10.1016\/j.amepre.2021.05.044_bib0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.15585\/mmwr.mm6718a5","article-title":"Access to syringe services programs - Kentucky, North Carolina, and West Virginia, 2013-2017","volume":"67","author":"Bixler","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.amepre.2021.05.044_bib0106","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/521166","article-title":"Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial","volume":"45","author":"Altice","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2021.05.044_bib0107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/00333549141291S105","article-title":"Integrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population","volume":"129","author":"Burr","year":"2014","journal-title":"Public Health Rep"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0108","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0109","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 5","key":"10.1016\/j.amepre.2021.05.044_bib0110","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1086\/377548","article-title":"Human immunodeficiency virus prevention and the potential of drug abuse treatment","volume":"37","author":"Metzger","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.amepre.2021.05.044_bib0111","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1080\/10826080601026027","article-title":"Needle exchange program utilization and entry into drug user treatment: is there a long-term connection in Baltimore, Maryland?","volume":"41","author":"Latkin","year":"2006","journal-title":"Subst Use Misuse"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0112","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jsat.2008.07.002","article-title":"Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program","volume":"36","author":"Havens","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"10.1016\/j.amepre.2021.05.044_bib0113","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","article-title":"The role of behavioral interventions in buprenorphine maintenance treatment: a review","volume":"174","author":"Carroll","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amepre.2021.05.044_bib0114","series-title":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-020-00438-4","article-title":"Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic","volume":"17","author":"Castillo","year":"2020","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.amepre.2021.05.044_bib0116","series-title":"Managing HIV and hepatitis C outbreaks among people who inject drugs: a guide for state and local health departments","year":"2018"},{"issue":"15","key":"10.1016\/j.amepre.2021.05.044_bib0117","doi-asserted-by":"crossref","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","article-title":"Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018","volume":"68","author":"Golden","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2021.05.044_bib0118","doi-asserted-by":"crossref","unstructured":"McClung RP, Atkins AD, Kilkenny M, et al. Response to a large HIV outbreak, Cabell County, West Virginia, 2018\u20132019. Am J Prev Med. 2021;61(5S1):S143-S150.","DOI":"10.1016\/j.amepre.2021.05.039"},{"key":"10.1016\/j.amepre.2021.05.044_bib0119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugpo.2017.12.003","article-title":"Multiple injections per injection episode: high-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana","volume":"52","author":"Broz","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs-Massachusetts, 2015-2018","volume":"110","author":"Alpren","year":"2020","journal-title":"Am J Public Health"},{"issue":"16","key":"10.1016\/j.amepre.2021.05.044_bib0121","doi-asserted-by":"crossref","first-page":"499","DOI":"10.15585\/mmwr.mm6916a2","article-title":"Notes from the field: outbreak of human immunodeficiency virus infection among persons who inject drugs - Cabell County, West Virginia, 2018-2019","volume":"69","author":"Atkins","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 5","key":"10.1016\/j.amepre.2021.05.044_bib0122","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1093\/infdis\/jiaa128","article-title":"Understanding the intersection of behavioral risk and social determinants of health and the impact on an outbreak of human immunodeficiency virus among persons who inject drugs in Philadelphia","volume":"222","author":"Kim","year":"2020","journal-title":"J Infect Dis"},{"issue":"9052","key":"10.1016\/j.amepre.2021.05.044_bib0123","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0140-6736(96)05439-6","article-title":"An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA","volume":"349","author":"Lurie","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0124","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1057\/jphp.2014.54","article-title":"State laws, syringe exchange, and HIV among persons who inject drugs in the United States: history and effectiveness","volume":"36","author":"Bramson","year":"2015","journal-title":"J Public Health Policy"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/journalofethics.2016.18.3.hlaw1-1603","article-title":"Needle exchange programs\u2019 status in U.S. politics","volume":"18","author":"Weinmeyer","year":"2016","journal-title":"AMA J Ethics"},{"issue":"1","key":"10.1016\/j.amepre.2021.05.044_bib0126","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","article-title":"Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs","volume":"16","author":"Allen","year":"2019","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0127","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/19371918.2015.1137522","article-title":"The significance of harm reduction as a social and healthcare intervention for injecting drug users: an exploratory study of a needle exchange program in Fresno, California","volume":"31","author":"Clarke","year":"2016","journal-title":"Soc Work Public Health"},{"issue":"2","key":"10.1016\/j.amepre.2021.05.044_bib0128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/ACM.0000000000003557","article-title":"The University of Miami Infectious Disease Elimination Act Syringe Services Program: a blueprint for student advocacy, education, and innovation","volume":"96","author":"Tookes","year":"2021","journal-title":"Acad Med"},{"issue":"1_suppl","key":"10.1016\/j.amepre.2021.05.044_bib0129","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1177\/0033354920921817","article-title":"State laws governing syringe services programs and participant syringe possession, 2014-2019","volume":"135","author":"Fern\u00e1ndez-Vi\u00f1a","year":"2020","journal-title":"Public Health Rep"},{"issue":"3","key":"10.1016\/j.amepre.2021.05.044_bib0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11904-018-0397-9","article-title":"Syringe decriminalization advocacy in red states: lessons from the North Carolina Harm Reduction Coalition","volume":"15","author":"Cloud","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"21","key":"10.1016\/j.amepre.2021.05.044_bib0131","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJMp1901276","article-title":"Lessons from Scott County - progress or paralysis on harm reduction?","volume":"380","author":"Kishore","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2021.05.044_bib0132","series-title":"Preventing HIV and hepatitis C among people who inject drugs: public funding for syringe services programs makes the difference","year":"2017"},{"key":"10.1016\/j.amepre.2021.05.044_bib0133","article-title":"Why Marion County doesn't have a needle exchange","author":"Rudavsky","year":"2017","journal-title":"IndyStar"},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0134","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10900-017-0325-8","article-title":"State of HIV in the U.S. deep south","volume":"42","author":"Reif","year":"2017","journal-title":"J Community Health"},{"key":"10.1016\/j.amepre.2021.05.044_bib0135","series-title":"HIV in the Southern United States","year":"2019"},{"key":"10.1016\/j.amepre.2021.05.044_bib0136","unstructured":"Consolidated Appropriations Act, H.R. 2029, S. 114-57, 114th Cong. (2015\u20132016)."},{"key":"10.1016\/j.amepre.2021.05.044_bib0137","series-title":"Determination of need for syringe services programs. Centers for Disease Control and Prevention","year":"2020"},{"issue":"10","key":"10.1016\/j.amepre.2021.05.044_bib0138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205466","article-title":"Qualitative case study of needle exchange programs in the Central Appalachian region of the United States","volume":"13","author":"Davis","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.amepre.2021.05.044_bib0139","unstructured":"American Rescue Plan Act of 2021, H.R. 1319, 117th Cong. (2021)."},{"issue":"5","key":"10.1016\/j.amepre.2021.05.044_bib0140","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.japh.2020.02.029","article-title":"Syringe services programs and real world research: an overview for pharmacists","volume":"60","author":"Carico","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.amepre.2021.05.044_bib0141","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ypmed.2018.02.026","article-title":"Public support for safe consumption sites and syringe services programs to combat the opioid epidemic","volume":"111","author":"McGinty","year":"2018","journal-title":"Prev Med"},{"key":"10.1016\/j.amepre.2021.05.044_bib0142","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102821","article-title":"Syringe services program (SSP) operational changes during the COVID-19 global outbreak","volume":"83","author":"Bartholomew","year":"2020","journal-title":"Int J Drug Policy"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721003895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721003895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:00:09Z","timestamp":1760083209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379721003895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0749379721003895"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2021.05.044","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syringe Services Programs\u2019 Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2021.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Journal of Preventive Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}